Dynamic Cardiac SPECT Imaging (SPECT)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01934985|
Recruitment Status : Unknown
Verified June 2015 by University of California, San Francisco.
Recruitment status was: Recruiting
First Posted : September 4, 2013
Last Update Posted : June 8, 2015
|Condition or disease|
|Coronary Artery Disease|
|Study Type :||Observational|
|Estimated Enrollment :||160 participants|
|Official Title:||Dynamic Cardiac SPECT Imaging|
|Study Start Date :||March 2012|
|Estimated Primary Completion Date :||September 2015|
Patients scheduled to have clinically indicated stress MPI with low pre-test likelihood (0-15%) of coronary disease based on criteria of Diamond and Forrester. And those who have already had a clinical indicated stress MPI in the last three years with a low likelihood of having active coronary disease with no significantly narrowed coronary arteries.
Patients in Group II who will have the dynamic imaging protocol studies after SCA, patients will be selected for protocol enlistment only if the decision is made by the patient's physician, based totally on clinical and social factors, that any considered revascularization intervention would not be performed on the day of diagnostic selective coronary angiography (SCA) and will be performed electively, at least 4 to 7 days later. Viability will be assessed in these patients only in the presence of WM abnormalities, and with serial analysis of WM, as described above. Patients will be followed for death or infarction or other events more than 3 months after study, for up to 3 years following participation in the protocol.
Patients found at SCA to have lesions of "borderline" clinical significance, preferably in the absence of other associated lesions.
Patients who were diagnosed with advanced heart failure including patients who had or will have cardiac resynchonization therapy (CRT) or a heart transplant.
- Coronary Flow Reserve [ Time Frame: Length of procedure- 90 min ]The coronary flow reserve will be measured by comparing the rest and stress exams on the dynamic SPECT scans using developed algorithms. The accuracy will be compared with clinical PET, coronary angiography, and clinical SPECT.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01934985
|Contact: Elias Botvinick, MDfirstname.lastname@example.org|
|United States, California|
|University of California, San Francisco Imaging Center||Recruiting|
|San Francisco, California, United States, 94107|
|Principal Investigator:||Elias Botvinick, MD||University of California, San Francisco|